journal article·2020-08Open access

A self-driven bioinspired nanovehicle by leukocyte membrane-hitchhiking for early detection and treatment of atherosclerosis

Guanghao Wu, Wei Wei, Jinfeng Zhang, Weidong Nie, Lan Yuan, Yuanyu Huang, Liping Zuo, Lili Huang, Xiaobo Xi, Hai-Yan Xie

Biomaterials· Volume 250

Abstract

Atherosclerosis, as a silent killer, remains one of the most common causes of human morbidity and mortality worldwide due to the lack of efficient strategy for early detection and targeted therapy. In this work, a self-driven bioinspired nanovehicle is developed, which can accurately manage early atherosclerosis with simultaneously multiple-targeting, dual-modality therapy as well as noninvasive magnetic resonance imaging (MRI). The magnetic nanoclusters (MNCs) with satisfactory superparamagnetism are camouflaged with leukocyte membranes, thus acquiring inherently targeting and transmigrating capabilities to intimal foam cells in early atherosclerotic lesions, which is validated using tailor-made microfluidic devices and transwell assays. Upon sequentially embedding an anti-inflammatory drug simvastatin (ST) and decorating a targetable apolipoprotein A-I mimetic 4F peptide (AP), the as-fabricated MNC@M-ST/AP exhibits excellent anti-atherosclerotic effects by alleviating inflammation and oxidative stress as well as promoting cholesterol efflux via RCT pathways. This bioinspired leukocyte membrane-hitchhiking strategy will open new perspectives for the future clinical translations of biocompatible nanosystem in early detection and treatment of atherosclerosis.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Extracellular vesicles in disease · Protease and Inhibitor Mechanisms · Caveolin-1 and cellular processes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (40)

Show source-provided references
1. Atherosclerosis: current pathogenesis and therapeutic options10.1038/nm.2538 ↗
2. Perspectives and opportunities for nanomedicine in the management of atherosclerosis10.1038/nrd3578 ↗
3. In Vivo targeting and imaging of atherosclerosis using multifunctional virus-like particles of simian virus 4010.1021/acs.nanolett.6b02386 ↗
4. Detection of atherosclerotic lesions and intimal macrophages using CD36-targeted nanovesicles10.1016/j.jconrel.2015.10.004 ↗
5. Comparison of in vivo targeting ability between cRGD and collagen-targeting peptide conjugated nano-carriers for atherosclerosis10.1016/j.jconrel.2017.11.033 ↗
6. Detection and treatment of atherosclerosis using nanoparticles: detection and treatment of atherosclerosis using nanoparticles10.1002/wnan.1412 ↗
7. Macrophages in the pathogenesis of atherosclerosis10.1016/j.cell.2011.04.005 ↗
8. The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis10.1146/annurev.me.43.020192.001251 ↗
9. Macrophage death and defective inflammation resolution in atherosclerosis10.1038/nri2675 ↗
10. Nanomedicine for the prevention, treatment and imaging of atherosclerosis, Nanomedicine: Nanotechnology
11. Recent advances in nanomedicines for the treatment of rheumatoid arthritis10.1039/C7BM00254H ↗
12. Development of macromolecular prodrug for rheumatoid arthritis10.1016/j.addr.2012.03.006 ↗
13. Targeted therapy of atherosclerosis by a broad-spectrum reactive oxygen species scavenging nanoparticle with intrinsic anti-inflammatory activity10.1021/acsnano.8b02037 ↗
14. Atherosclerotic plaque targeting mechanism of long-circulating nanoparticles established by multimodal imaging10.1021/nn506750r ↗
15. Leukocyte-mediated delivery of nanotherapeutics in inflammatory and tumor sites10.7150/thno.18069 ↗
16. Neutrophil-based drug delivery systems, adv
17. Biomimetic nanoparticles for inflammation targeting10.1016/j.apsb.2017.12.002 ↗
18. A biomimetic nanosponge that absorbs pore-forming toxins10.1038/nnano.2013.54 ↗
19. Modulating antibacterial immunity via bacterial membrane-coated nanoparticles10.1021/nl504798g ↗
20. Erythrocyte-membrane-enveloped perfluorocarbon as nanoscale Artificial red blood cells to relieve tumor hypoxia and enhance cancer radiotherapy10.1002/adma.201701429 ↗
21. Therapeutic microparticles functionalized with biomimetic cardiac stem cell membranes and secretome10.1038/ncomms13724 ↗
22. Biomimetic O2-Evolving metal-organic framework nanoplatform for highly efficient photodynamic therapy against hypoxic tumor10.1016/j.biomaterials.2018.06.007 ↗
23. Therapeutic efficacy-potentiated and diseased organ-targeting nanovesicles derived from mesenchymal stem cells for spinal cord injury treatment10.1021/acs.nanolett.8b01816 ↗
24. Mesenchymal stem cell/red blood cell-inspired nanoparticle therapy in mice with carbon tetrachloride-induced acute liver failure10.1021/acsnano.8b00553 ↗
25. Cancer cell membrane-biomimetic nanoprobes with two-photon excitation and near-infrared emission for intravital tumor fluorescence imaging10.1021/acsnano.7b07716 ↗
26. Magnetic mesoporous silica nanoparticles cloaked by red blood cell membranes: applications in cancer therapy10.1002/ange.201712996 ↗
27. Nanoparticle biointerfacing by platelet membrane cloaking10.1038/nature15373 ↗
28. Cell membrane coating nanotechnology10.1002/adma.201706759 ↗
29. G.Ma, H.-Y. Xie, biomimetic immuno-magnetosomes for high-PerformanceEnrichment of circulating tumor cells10.1002/adma.201601643 ↗
30. Biomimetic magnetosomes as versatile artificial antigen-presenting cells to potentiate T-cell-based anticancer therapy10.1021/acsnano.7b04955 ↗
31. Construction of a biomimetic magnetosome and its application as a SiRNA carrier for high-performance anticancer therapy10.1002/adfm.201703326 ↗
32. A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation10.1038/ncomms4065 ↗
33. Recent advances in managing atherosclerosis via nanomedicine10.1002/smll.201702793 ↗
34. Multifunctional dextran sulfate-coated reconstituted high density lipoproteins target macrophages and promote beneficial antiatherosclerotic mechanisms10.1021/acs.bioconjchem.6b00600 ↗
35. Biodegradable synthetic high-density lipoprotein nanoparticles for atherosclerosis10.1073/pnas.1301929110 ↗
36. Saikosaponin a inhibits lipopolysaccharide-oxidative stress and inflammation in Human umbilical vein endothelial cells via preventing TLR4 translocation into lipid rafts10.1016/j.freeradbiomed.2015.10.407 ↗
37. Crocetin inhibits lipopolysaccharide-induced inflammatory response in human umbilical vein endothelial cells10.1159/000452559 ↗
38. Oxidized LDL regulates macrophage gene expression through ligand activation of PPAR10.1016/S0092-8674(00)81574-3 ↗
39. HDL apolipoprotein-related peptides in the treatment of atherosclerosis and other inflammatory disorders10.2174/138161210793292492 ↗
40. Copper sulfide nanoparticles as a photothermal switch for TRPV1 signaling to attenuate atherosclerosis10.1038/s41467-017-02657-z ↗